XIN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shandong Xinhua Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 0.615 EUR -3.91% Market Closed

Market Cap: €678m

S	Shandong Xinhua Pharmaceutical Co Ltd SWB:XIN	CN
	Felix Industries Ltd NSE:FELIX	IN
	Shandong Xinhua Pharmaceutical Co Ltd F:XIN	CN
J	JTEKT Corp OTC:JTEKF	JP
	LunR Royalties Corp F:A6E	CA
M	Momentum Group AB OTC:MMGRF	SE
R	Riot Platforms Inc SWB:AP4N	US
K	KME Group SpA LSE:0MB2	IT
	Hillgrove Resources Ltd ASX:KAN	AU
	BrainCool AB (publ) STO:BRAIN	SE

Profitability Summary

Shandong Xinhua Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

17%

Sustainable 3Y Average Gross Margin

23%

Declining Gross Margin

28% > 17%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

7% > 4%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 3%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.